ConocoPhillips is one of America's best employers. Photo courtesy of ConocoPhillips

A major Houston energy player is raking in the awards. Austin-based Indeed recently revealed its list of the top 50 workplaces in the U.S., and Houston-based ConocoPhillips is joined by two other Texas companies.

To identify these top-rated workplaces, Indeed's data team mined the 100 million employee reviews on its own website and analyzed those from companies also featured on this year's Fortune 500 list.

ConocoPhillips has been exploring and producing oil and natural gas since 1875 and maintains its secret to success lies in the mantra "it's not just what we do — it's how we do it." It lands at No. 35, with employees praising the work-life balance and noting how they feel valued and respected.

Coming in at No. 3, Southwest earned raves for its supportive and fun environment, competitive pay, flexible work schedule, and enviable benefits (including free travel). Founded in 1967, the world's largest low-cost carrier also ranked No. 11 on Fortune's list of world's most admired companies for 2019.

Once based in Aliso Viejo, California, construction and engineering giant Fluor Corp. moved its headquarters to Irving in 2006. It takes the No. 17 spot on Indeed's list, and also resides on the Fortune 500 list with a 2018 revenue of $19.2 billion and more than 53,000 employees worldwide.

California clinches the rest of the top five, with Adobe (San Jose), Facebook (Menlo Park), Live Nation (Beverly Hills), and Intuit (Mountain View) demonstrating how tech and entertainment continue to remain popular industries for eager employees.

------

This story originally appeared on CultureMap.com.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Axiom Space-tested cancer drug advances to clinical trials

mission critical

A cancer-fighting drug tested aboard several Axiom Space missions is moving forward to clinical trials.

Rebecsinib, which targets a cancer cloning and immune evasion gene, ADAR1, has received FDA approval to enter clinical trials under active Investigational New Drug (IND) status, according to a news release. The drug was tested aboard Axiom Mission 2 (Ax-2) and Axiom Mission 3 (Ax-3). It was developed by Aspera Biomedicine, led by Dr. Catriona Jamieson, director of the UC San Diego Sanford Stem Cell Institute (SSCI).

The San Diego-based Aspera team and Houston-based Axiom partnered to allow Rebecsinib to be tested in microgravity. Tumors have been shown to grow more rapidly in microgravity and even mimic how aggressive cancers can develop in patients.

“In terms of tumor growth, we see a doubling in growth of these little mini-tumors in just 10 days,” Jamieson explained in the release.

Rebecsinib took part in the patient-derived tumor organoid testing aboard the International Space Station. Similar testing is planned to continue on Axiom Station, the company's commercial space station that's currently under development.

Additionally, the drug will be tested aboard Ax-4 under its active IND status, which was targeted to launch June 25.

“We anticipate that this monumental mission will inform the expanded development of the first ADAR1 inhibitory cancer stem cell targeting drug for a broad array of cancers," Jamieson added.

According to Axiom, the milestone represents the potential for commercial space collaborations.

“We’re proud to work with Aspera Biomedicines and the UC San Diego Sanford Stem Cell Institute, as together we have achieved a historic milestone, and we’re even more excited for what’s to come,” Tejpaul Bhatia, the new CEO of Axiom Space, said in the release. “This is how we crack the code of the space economy – uniting public and private partners to turn microgravity into a launchpad for breakthroughs.”

Chevron enters the lithium market with major Texas land acquisition

to market

Chevron U.S.A., a subsidiary of Houston-based energy company Chevron, has taken its first big step toward establishing a commercial-scale lithium business.

Chevron acquired leaseholds totaling about 125,000 acres in Northeast Texas and southwest Arkansas from TerraVolta Resources and East Texas Natural Resources. The acreage contains a high amount of lithium, which Chevron plans to extract from brines produced from the subsurface.

Lithium-ion batteries are used in an array of technologies, such as smartwatches, e-bikes, pacemakers, and batteries for electric vehicles, according to Chevron. The International Energy Agency estimates lithium demand could grow more than 400 percent by 2040.

“This acquisition represents a strategic investment to support energy manufacturing and expand U.S.-based critical mineral supplies,” Jeff Gustavson, president of Chevron New Energies, said in a news release. “Establishing domestic and resilient lithium supply chains is essential not only to maintaining U.S. energy leadership but also to meeting the growing demand from customers.”

Rania Yacoub, corporate business development manager at Chevron New Energies, said that amid heightening demand, lithium is “one of the world’s most sought-after natural resources.”

“Chevron is looking to help meet that demand and drive U.S. energy competitiveness by sourcing lithium domestically,” Yacoub said.

---

This article originally appeared on EnergyCapital.